ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response.
Sousa LG, Rajapakshe K, Rodriguez Canales J, Chin RL, Feng L, Wang Q, Barrese TZ, Massarelli E, William W, Johnson FM, Ferrarotto R, Wistuba I, Coarfa C, Lee J, Wang J, Melief CJM, Curran MA, Glisson BS.
Sousa LG, et al. Among authors: chin rl.
J Immunother Cancer. 2022 Feb;10(2):e004232. doi: 10.1136/jitc-2021-004232.
J Immunother Cancer. 2022.
PMID: 35193933
Free PMC article.
Clinical Trial.